Wednesday, October 30, 2013

PECOFacet Opens New Office in Dubai



ME Newswire / Business Wire

MINERAL WELLS, Texas - Tuesday, October 29th 2013

PECOFacet, a subsidiary of CLARCOR Inc. (NYSE: CLC), announced today the opening of its new office in Dubai. The office, located in the Dubai Airport Free Trade Zone, is part of CLARCOR’s PECOFacet Division, which is included within CLARCOR’s Industrial/Environmental Filtration segment. An opening ceremony was held in Dubai and was attended by key customers, distributors, officials from the Dubai Airport Free Zone Authority, as well as PECOFacet’s President, Vice President of Europe, Middle East and Africa, and Vice President of Global Sales.

Chris Conway, CLARCOR’s CEO, said: “PECOFacet’s new office in Dubai represents our commitment to the Middle East and is another step in our strategy of making CLARCOR the world’s leading oil, gas, chemical and fuel filtration provider.”

Scott Thompson, PECOFacet’s President, said: “We are very excited about our new office in Dubai. While PECOFacet has been providing innovative solutions throughout the Middle East for many years, our new office brings the next level of responsiveness and service to our customers in the Middle East. PECOFacet maintains a commitment to, and investment in, research and development which has resulted in significant technology advances in filtration, separation, and coalescence. Several key examples of which are PECOFacet’s patented PEACH® Gemini PuraSep® gas coalescers, XtreamPure® liquid housings and the PEACH® filter cartridge manufacturing process.”

CLARCOR is based in Franklin, Tennessee, and is a diversified marketer and manufacturer of mobile, industrial and environmental filtration products and consumer and industrial packaging products sold in domestic and international markets. Common shares of the Company are traded on the New York Stock Exchange under the symbol CLC.

Contacts

PECOFacet, Inc.

Michelle Hewitt, 800-877-7326









Permalink: http://me-newswire.net/news/8995/en

No comments:

Post a Comment